BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6338903)

  • 1. Decreased prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardation.
    Jogee M; Myatt L; Elder MG
    Br J Obstet Gynaecol; 1983 Mar; 90(3):247-50. PubMed ID: 6338903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardation.
    Jeremy JY; Barradas MA; Mikhailidis DP; Dandona P
    Br J Obstet Gynaecol; 1983 Nov; 90(11):1097-9. PubMed ID: 6357272
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease prostacyclin production: a characteristic of chronic placental insufficiency syndromes.
    Stuart MJ; Clark DA; Sunderji SG; Allen JB; Yambo T; Elrad H; Slott JH
    Lancet; 1981 May; 1(8230):1126-8. PubMed ID: 6112487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased low-density lipoprotein susceptibility to oxidation in pregnancies and fetal growth restriction.
    Sánchez-Vera I; Bonet B; Viana M; Quintanar A; López-Salva A
    Obstet Gynecol; 2005 Aug; 106(2):345-51. PubMed ID: 16055586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostacyclin production by human placental cells in short-term culture.
    Jogee M; Myatt L; Moore P; Elder MG
    Placenta; 1983; 4(3):219-30. PubMed ID: 6353402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation by human chorionic gonadotropin of prostaglandin synthesis by early human placental tissue.
    North RA; Whitehead R; Larkins RG
    J Clin Endocrinol Metab; 1991 Jul; 73(1):60-70. PubMed ID: 1904453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased placental progesterone may cause decreased placental prostacyclin production in preeclampsia.
    Walsh SW; Coulter S
    Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1586-92. PubMed ID: 2513720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction.
    Lappas M; McCracken S; McKelvey K; Lim R; James J; Roberts CT; Fournier T; Alfaidy N; Powell KL; Borg AJ; Morris JM; Leaw B; Singh H; Ebeling PR; Wallace EM; Parry LJ; Dimitriadis E; Murthi P
    Mol Hum Reprod; 2018 Feb; 24(2):94-109. PubMed ID: 29272530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental prostacyclin production in normal and toxemic pregnancies.
    Walsh SW; Behr MJ; Allen NH
    Am J Obstet Gynecol; 1985 Jan; 151(1):110-5. PubMed ID: 3881024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does or can human placenta produce prostacyclin?
    Keirse MJ; Erwich JJ; Klok G
    Placenta; 1986; 7(1):37-42. PubMed ID: 3085081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental and fetal growth retardation following partial progesterone withdrawal in rat pregnancy.
    Mark PJ; Smith JT; Waddell BJ
    Placenta; 2006; 27(2-3):208-14. PubMed ID: 16338466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine alters placental production of thromboxane and prostacyclin.
    Monga M; Chmielowiec S; Andres RL; Troyer LR; Parisi VM
    Am J Obstet Gynecol; 1994 Oct; 171(4):965-9. PubMed ID: 7943110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of C-type natriuretic peptide in human placenta and myometrium in normal pregnancies and pregnancies complicated by intrauterine growth retardation. Preliminary results.
    Stepan H; Faber R; Stegemann S; Schultheiss HP; Walther T
    Fetal Diagn Ther; 2002; 17(1):37-41. PubMed ID: 11803215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth.
    Roos S; Jansson N; Palmberg I; Säljö K; Powell TL; Jansson T
    J Physiol; 2007 Jul; 582(Pt 1):449-59. PubMed ID: 17463046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone and prostanoid production by bovine binucleate trophoblastic cells.
    Reimers TJ; Ullmann MB; Hansel W
    Biol Reprod; 1985 Dec; 33(5):1227-36. PubMed ID: 3865692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation.
    Grancha S; Estellés A; Gilabert J; Chirivella M; España F; Aznar J
    Thromb Haemost; 1996 Nov; 76(5):761-7. PubMed ID: 8950787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prostacyclin analogue crosses the in vitro perfused human placenta and improves transfer in some pathologic states.
    Kuhn DC; Walenga RW; Stuart MJ
    Am J Perinatol; 1991 May; 8(3):179-84. PubMed ID: 2029277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production.
    Walsh SW
    Am J Obstet Gynecol; 1985 Jun; 152(3):335-40. PubMed ID: 3923838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uteroplacental hemostasis in intrauterine fetal growth retardation.
    Sheppard BL; Bonnar J
    Semin Thromb Hemost; 1999; 25(5):443-6. PubMed ID: 10625199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.